OVERVIEW

 

Click here to see programme overview

 

DETAILED PROGRAMME 

 

1. STRATEGIES FOR PATIENT SPECIFIC QA (PRE-TREATMENT OR IN VIVO) 

Chairs: Jeroen Van der Kamer & Dirk Verellen 

Patient specific QA for IMRT, VMAT and SBRT is routinely performed in most departments. As the number of patients treated using these techniques is increasing, there is a need to reach a consensus on what plans should be checked and if so, what would be the optimal method...

Read the full description here  

 

2.  PREDICTIVE MODELS OF TOXICITY IN RT 

Chairs: Tiziana Rancati & Claudio Fiorino 

Our (manual or automatic) planning optimization is driven by the knowledge (often very lacking) of quantitative dose-volume effect relationships, then every progress in this field has a huge and rapid impact on the way we treat our patients everywhere. This is the main reason why this is a very active field of research and practice, involving the interest of many medical physicists working in clinics, not only University colleagues....

Read the full description here 

 

3. IMPROVING RANGE ACCURACY IN PARTICLE THERAPY 

Chairs: Christian Richter & Ludvig Muren

For the last two decades the large range uncertainty margins applied in particle therapy have been unchanged, hindering the optimal use of the physical advantage of the particles’ dose distribution in clinical practice. With the recent progress in range prediction and range verification, a reduction of range uncertainties seems tangible in the near future...

Read the full description here 

 

4. REALTIME AND ADAPTIVE MANAGEMENT OF ANATOMICAL VARIATIONS 

Chairs: Ben Heijmen & Marianne Aznar

Realtime compensation for (respiratory) tumor motion and adjustment of treatment plans (ART) to compensate for anatomy variations still face big challenges but offer high potential: reduction of doses in organs at risk and dose escalation in the target..

Read the full description here 

5. QUANTITATIVE IMAGING FOR TREATMENT PLANNING

Chairs: Uulke Van der Heide & Daniela Thorwarth

Functional imaging with PET and MRI is increasingly used in the preparation of patients for radiotherapy, for selection of patients for a particular treatment, for delineation of the target, or for dose painting. While there is a vast body of literature on imaging biomarkers for response after radiotherapy, there is also a substantial variability in methodology...

Read the full description here 

 

 

Back to main page